2009
DOI: 10.1186/1750-2187-4-6
|View full text |Cite
|
Sign up to set email alerts
|

Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis

Abstract: Background: Glucocorticoid hormones (GCs) induce apoptosis of leukemic T-cells by transcriptional regulation via the GC receptor, GR. In the human leukemic CEM cell culture model, RCAN1 has been identified as one of the genes that is specifically upregulated only in the GCsensitive CEM C7-14 cells, but not in the GC-resistant CEM-C1-15 sister cells in correlation with GC-evoked apoptosis. RCAN1 gene encodes two major protein isoforms of the regulator of calcineurin (RCAN1), RCAN1-1 and RCAN1-4 via alternative … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
23
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(24 citation statements)
references
References 38 publications
(61 reference statements)
1
23
0
Order By: Relevance
“…RCAN1-1L levels can be specifically increased by glucocorticoids [29,30], whose production is known to be stimulated by multiple stresses. High glucocorticoid levels can lead to neurodegeneration, and we hypothesize that stress-induced production of glucocorticoids may actually cause neurodegeneration by elevating RCAN1-1L.…”
Section: Stress-induced Production Of Glucocorticoids May Exacerbate mentioning
confidence: 99%
“…RCAN1-1L levels can be specifically increased by glucocorticoids [29,30], whose production is known to be stimulated by multiple stresses. High glucocorticoid levels can lead to neurodegeneration, and we hypothesize that stress-induced production of glucocorticoids may actually cause neurodegeneration by elevating RCAN1-1L.…”
Section: Stress-induced Production Of Glucocorticoids May Exacerbate mentioning
confidence: 99%
“…CaN inhibitors, including tacrolimus (FK506) and cyclosporine, are widely used drugs for the treatment of NS in cases in which GCs are clinically ineffective. Previous reports have demonstrated the ability of Dex to stimulate CaN phosphatase activity in some cell types and suppress it in other cell types (Tumlin et al, 1997;Hirakawa et al, 2009). To date, the ability of neither Rosi, Pio, nor even Dex to alter CaN activity in podocytes has been studied.…”
Section: Thiazolidinediones Protect Podocytes 395mentioning
confidence: 99%
“…After ischemic insult, up-regulation of RCAN1.4 in the peri-infarct cortex has also been reported (7). RCAN1.1, a 36-to 41-kDa protein, is up-regulated by glucocorticoid and dexamethasone in human leukemic cells via the glucocorticoid response element (8,9). Chronic RCAN1 overexpression is associated with DS and Alzheimer disease, and RCAN1 deficiency has been reported in Huntington disease (2,4,10,11).…”
mentioning
confidence: 94%